Inventor · disambiguated record
Michael D. Kalos
Also filed as: KALOS MICHAEL · KALOS MICHAEL D · KALOS MICHAEL DEWAIN
43 granted patents·49 pending applications·3,405 citations·filing 1999–2024
99Inventor score
Top patents by PatentIndex Score
92 records- 0199US9540445B2Compositions and methods for treatment of cancerUNIV PENNSYLVANIA·Filed 2016·Granted Jan 10, 2017·99 cites·30 claims
- 0299US9518123B2Compositions and methods for treatment of cancerUNIV PENNSYLVANIA·Filed 2016·Granted Dec 13, 2016·92 cites·26 claims
- 0399US9481728B2Compositions and methods for treatment of cancerUNIV PENNSYLVANIA·Filed 2015·Granted Nov 1, 2016·100 cites·30 claims
- 0499US9464140B2Compositions and methods for treatment of cancerUNIV PENNSYLVANIA·Filed 2016·Granted Oct 11, 2016·117 cites·28 claims
- 0599US9328156B2Use of chimeric antigen receptor-modified T cells to treat cancerUNIV PENNSYLVANIA·Filed 2013·Granted May 3, 2016·127 cites·15 claims
- 0699US9102761B2Compositions for treatment of cancerUNIV PENNSYLVANIA·Filed 2014·Granted Aug 11, 2015·250 cites·30 claims
- 0799US9102760B2Compositions for treatment of cancerUNIV PENNSYLVANIA·Filed 2014·Granted Aug 11, 2015·254 cites·30 claims
- 0899US9101584B2Methods for treatment of cancerUNIV PENNSYLVANIA·Filed 2014·Granted Aug 11, 2015·250 cites·30 claims
- 0999US8975071B1Compositions for treatment of cancerUNIV PENNSYLVANIA·Filed 2014·Granted Mar 10, 2015·255 cites·17 claims
- 1099US8916381B1Methods for treatment of cancerUNIV PENNSYLVANIA·Filed 2014·Granted Dec 23, 2014·276 cites·28 claims
- 1199US8911993B2Compositions for treatment of cancerUNIV PENNSYLVANIA·Filed 2013·Granted Dec 16, 2014·474 cites·21 claims
- 1299US8906682B2Methods for treatment of cancerUNIV PENNSYLVANIA·Filed 2013·Granted Dec 9, 2014·507 cites·30 claims
- 1398US9499629B2Use of chimeric antigen receptor-modified T-cells to treat cancerJUNE CARL H·Filed 2011·Granted Nov 22, 2016·151 cites·53 claims
- 1497US9573988B2Effective targeting of primary human leukemia using anti-CD123 chimeric antigen receptor engineered T cellsBROGDON JENNIFER·Filed 2014·Granted Feb 21, 2017·87 cites·94 claims
- 1595US10603378B2Toxicity management for anti-tumor activity of CARsUNIV PENNSYLVANIA·Filed 2018·Granted Mar 31, 2020·10 cites·28 claims
- 1695US9572836B2Methods for assessing the suitability of transduced T cells for administrationUNIV PENNSYLVANIA·Filed 2013·Granted Feb 21, 2017·33 cites·14 claims
- 1795US6800746B2Compositions and methods for the therapy and diagnosis of prostate cancerCORIXA CORP·Filed 2001·Granted Oct 5, 2004·69 cites·9 claims
- 1892US11273219B2Toxicity management for anti-tumor activity of CARsUNIV PENNSYLVANIA·Filed 2018·Granted Mar 15, 2022·4 cites·20 claims
- 1991US11028177B2Effective targeting of primary human leukemia using anti-CD123 chimeric antigen receptor engineered T cellsNOVARTIS AG·Filed 2017·Granted Jun 8, 2021·4 cites·47 claims
- 2089US10906983B2Anti-CD137 antibodiesLILLY CO ELI·Filed 2018·Granted Feb 2, 2021·6 cites·9 claims
- 2189US6737514B1Compositions and methods for the therapy and diagnosis of lung cancerCORIXA CORP·Filed 2000·Granted May 18, 2004·27 cites·5 claims
- 2289US6620922B1Compositions and methods for the therapy and diagnosis of prostate cancerCORIXA CORP·Filed 2000·Granted Sep 16, 2003·27 cites·10 claims
- 2388US6630305B1Compositions and methods for the therapy and diagnosis of prostate cancerCORIXA CORP·Filed 2000·Granted Oct 7, 2003·23 cites·4 claims
- 2487US6943236B2Compositions and methods for the therapy and diagnosis of prostate cancerCORIXA CORP·Filed 2001·Granted Sep 13, 2005·21 cites·1 claims
- 2586US7425607B2Compositions comprising a lung tumor antigenCORIXA CORP·Filed 2005·Granted Sep 16, 2008·8 cites·4 claims
- 2685US6818751B1Compositions and methods for the therapy and diagnosis of prostate cancerCORIXA CORP·Filed 2000·Granted Nov 16, 2004·16 cites·4 claims
- 2785US6426072B1Compositions and methods for the therapy and diagnosis of lung cancerCORIXA CORP·Filed 2000·Granted Jul 30, 2002·11 cites·6 claims
- 2884US6759515B1Compositions and methods for the therapy and diagnosis of prostate cancerCORIXA CORP·Filed 2000·Granted Jul 6, 2004·14 cites·2 claims
- 2982US7517952B1Compositions and methods for the therapy and diagnosis of prostate cancerCORIXA CORP·Filed 2000·Granted Apr 14, 2009·7 cites·3 claims
- 3082US7048931B1Compositions and methods for the therapy and diagnosis of prostate cancerCORIXA CORP·Filed 2000·Granted May 23, 2006·6 cites·6 claims
- 3182US6518256B1Compounds and methods for therapy and diagnosis of lung cancerCORIXA CORP·Filed 2000·Granted Feb 11, 2003·11 cites·9 claims
- 3281US7033827B2Prostate-specific polynucleotide compositionsCORIXA CORP·Filed 2002·Granted Apr 25, 2006·7 cites·7 claims
- 3378US6531315B1Compositions and methods for the therapy and diagnosis of lung cancerCORIXA CORP·Filed 2000·Granted Mar 11, 2003·7 cites·6 claims
- 3478US6482597B1Compounds and methods for therapy and diagnosis of lung cancerCORIXA CORP·Filed 2000·Granted Nov 19, 2002·7 cites·6 claims
- 3578US2024261328A1Use of cart19 to deplete normal b cells to induce toleranceUNIV PENNSYLVANIA·Filed 2023·Application pending·0 cites
- 3678US2025333525A1Anti-cd137 antibodies for combination with anti-pd-1 antibodiesLILLY CO ELI·Filed 2024·Application pending·0 cites
- 3777US7049063B2Methods for diagnosis of lung cancerCORIXA CORP·Filed 2000·Granted May 23, 2006·7 cites·2 claims
- 3876US7202342B1Compositions and methods for the therapy and diagnosis of prostate cancerCORIXA CORP·Filed 2000·Granted Apr 10, 2007·3 cites·6 claims
- 3976US2008219990A1Compositions and methods for the therapy and diagnosis of breast cancerCORIXA CORP·Filed 2007·Application pending·0 cites
- 4075US6894146B1Compositions and methods for the therapy and diagnosis of prostate cancerCORIXA CORP·Filed 2000·Granted May 17, 2005·4 cites·4 claims
- 4175US2023013642A1Toxicity Management for Anti-Tumor Activity of CARsUNIV PENNSYLVANIA·Filed 2022·Application pending·0 cites
- 4274US7939646B2Compositions and methods for the therapy and diagnosis of prostate cancerCORIXA CORP·Filed 2007·Granted May 10, 2011·0 cites·11 claims
- 4374US6329505B1Compositions and methods for therapy and diagnosis of prostate cancerCORIXA CORP·Filed 1999·Granted Dec 11, 2001·34 cites·5 claims
- 4474US2008206245A1Compositions and methods for the therapy and diagnosis of breast cancerCORIXA CORP·Filed 2007·Application pending·0 cites
- 4574US2023034117A1Compositions and methods for regulating car t cellsUNIV PENNSYLVANIA·Filed 2022·Application pending·0 cites
- 4674US2008311123A1Compositions and methods for the therapy and diagnosis of breast cancerCORIXA CORP·Filed 2007·Application pending·0 cites
- 4773US12453771B2Methods of treating cancer using anti-CD137 antibodiesLILLY CO ELI·Filed 2022·Granted Oct 28, 2025·0 cites·13 claims
- 4871US2008219991A1Compositions and methods for the therapy and diagnosis of breast cancerCORIXA CORP·Filed 2007·Application pending·0 cites
- 4971US2006287513A1Compositions and methods for the therapy and diagnosis of breast cancerCORIXA CORP·Filed 2006·Application pending·0 cites
- 5071US2008206234A1Compositions and methods for the therapy and diagnosis of breast cancerCORIXA CORP·Filed 2007·Application pending·0 cites
Showing the top 50 of 92 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Michael D. Kalos files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →